These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21210267)

  • 1. Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene.
    Joshi R; Phatarpekar A
    World J Pediatr; 2011 Nov; 7(4):371-2. PubMed ID: 21210267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent neonatal diabetes due to KCNJ11 gene mutation.
    Letha S; Mammen D; Valamparampil JJ
    Indian J Pediatr; 2007 Oct; 74(10):947-9. PubMed ID: 17978456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
    Lauridsen MH; Boesgaard TW; Pedersen OB; Hansen T; Hertz B
    Ugeskr Laeger; 2009 Jun; 171(23):1923-4. PubMed ID: 19500515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature.
    He B; Li X; Zhou Z
    J Diabetes; 2021 Jan; 13(1):19-32. PubMed ID: 32935446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
    Mohamadi A; Clark LM; Lipkin PH; Mahone EM; Wodka EL; Plotnick LP
    Pediatr Diabetes; 2010 May; 11(3):203-7. PubMed ID: 19686306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
    Slingerland AS; Nuboer R; Hadders-Algra M; Hattersley AT; Bruining GJ
    Diabetologia; 2006 Nov; 49(11):2559-63. PubMed ID: 17047922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNJ11 in-frame 15-bp deletion leading to glibenclamide-responsive neonatal diabetes mellitus in a Chinese child.
    Yang W; Wei H; Sang Y
    J Pediatr Endocrinol Metab; 2013; 26(7-8):743-6. PubMed ID: 24266052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AV59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child.
    Sang Y; Ni G; Gu Y; Liu M
    J Pediatr Endocrinol Metab; 2011; 24(9-10):763-6. PubMed ID: 22145471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
    Chan YM; Laffel LM
    Pediatr Diabetes; 2007 Aug; 8(4):235-8. PubMed ID: 17659066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child.
    Yang W; Wei H; Sang Y
    J Pediatr Endocrinol Metab; 2013; 26(5-6):591-4. PubMed ID: 23640936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
    Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
    Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas.
    Dupont J; Pereira C; Medeira A; Duarte R; Ellard S; Sampaio L
    J Pediatr Endocrinol Metab; 2012; 25(3-4):367-70. PubMed ID: 22768671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical features of K
    Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
    Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene.
    Della Manna T; Battistim C; Radonsky V; Savoldelli RD; Damiani D; Kok F; Pearson ER; Ellard S; Hattersley AT; Reis AF
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1350-5. PubMed ID: 19169493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.
    Abbasi F; Saba S; Ebrahim-Habibi A; Sayahpour FA; Amiri P; Larijani B; Amoli MM
    Mol Diagn Ther; 2012 Apr; 16(2):109-14. PubMed ID: 22471336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient neonatal diabetes due to activating mutation in the ABCC8 gene encoding SUR1.
    Batra CM; Gupta N; Atwal G; Gupta V
    Indian J Pediatr; 2009 Nov; 76(11):1169-72. PubMed ID: 20092027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.
    Siklar Z; Ellard S; Okulu E; Berberoğlu M; Young E; Savaş Erdeve S; Mungan IA; Hacihamdioğlu B; Erdeve O; Arsan S; Oçal G
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1077-80. PubMed ID: 22308870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.
    Al-Mahdi M; Al Mutair A; Al Balwi M; Hussain K
    Ann Saudi Med; 2010; 30(2):162-4. PubMed ID: 20220270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.
    Mlynarski W; Tarasov AI; Gach A; Girard CA; Pietrzak I; Zubcevic L; Kusmierek J; Klupa T; Malecki MT; Ashcroft FM
    Nat Clin Pract Neurol; 2007 Nov; 3(11):640-5. PubMed ID: 17982434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
    Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.